This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Norgine Bv. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Ajit Kumar Behera: Innovator in CCR9 Modulation
Introduction
Ajit Kumar Behera is a notable inventor based in Dist-Nayagarh, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the CCR9 receptor. His work has implications for treating various inflammatory and immune disorders.
Latest Patents
Ajit Kumar Behera holds a patent for "Compounds useful as CCR9 modulators." This invention relates to compounds that can modulate the function of the CCR9 receptor by acting as partial agonists, antagonists, or inverse agonists. These compounds may be beneficial in treating, preventing, or ameliorating diseases associated with CCR9 activation, including inflammatory bowel diseases (IBD).
Career Highlights
Ajit Kumar Behera is currently associated with Norgine Bv, where he continues to advance his research in pharmacology and drug development. His innovative approach to CCR9 modulation has positioned him as a key figure in the field.
Collaborations
Some of his notable coworkers include Rajagopal Bakthavatchalam and Manas Kumar Basu. Their collaborative efforts contribute to the ongoing research and development in the area of CCR9 modulators.
Conclusion
Ajit Kumar Behera's work in developing CCR9 modulators showcases his commitment to advancing medical science. His contributions are vital for addressing inflammatory and immune disorders, making a significant impact in the field of pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile